{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:14:13Z","timestamp":1778037253939,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"am","delay-in-days":268,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F30DA057093"],"award-info":[{"award-number":["F30DA057093"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA039167"],"award-info":[{"award-number":["R01DA039167"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA011792"],"award-info":[{"award-number":["R01DA011792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043204"],"award-info":[{"award-number":["R01DA043204"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neuropharm.2024.110002","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:09:26Z","timestamp":1715702966000},"page":"110002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pKa fluorinated fentanyl analogs, FF3 and NFEPP"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8635-6558","authenticated-orcid":false,"given":"Shelley R.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0970-8118","authenticated-orcid":false,"given":"Kristian","family":"Cowart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace H.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron A.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1990-0589","authenticated-orcid":false,"given":"Jacob P.","family":"Haskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally L.","family":"Huskinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus F.","family":"Brackeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2024.110002_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physiol.00030.2015","article-title":"ASICs mediate pain and inflammation in musculoskeletal diseases","volume":"30","author":"Abdelhamid","year":"2015","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75509-4","article-title":"A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors","volume":"10","author":"Baamonde","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110002_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s11064-018-2542-7","article-title":"The peripheral versus central antinociception of a novel opioid agonist: acute inflammatory pain in rats","volume":"43","author":"Balogh","year":"2018","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110002_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2022.2114898","article-title":"Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids","volume":"15","author":"Bedene","year":"2022","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34582-6","article-title":"Molecular pain markers correlate with pH-sensitive MRI signal in a pig model of disc degeneration","volume":"8","author":"Bez","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110002_bib6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.55.8.1213","article-title":"Increased skin lactate in complex regional pain syndrome: evidence for tissue hypoxia?","volume":"55","author":"Birklein","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110002_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10877-017-0093-0","article-title":"Low minute ventilation episodes during anesthesia recovery following intraperitoneal surgery as detected by a non-invasive respiratory volume monitor","volume":"32","author":"Cavalcante","year":"2018","journal-title":"J. Clin. Monit. Comput."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/art.1780090106","article-title":"Measurement of synovial fluid pH in normal and arthritic knees","volume":"9","author":"Cummings","year":"1966","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2024.110002_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55886-1","article-title":"pK(a) of opioid ligands as a discriminating factor for side effects","volume":"9","author":"Del Vecchio","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110002_bib10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","article-title":"Novel opioid analgesics and side effects","volume":"8","author":"Del Vecchio","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110002_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pharmthera.2010.08.006","article-title":"Acid-sensing ion channels (ASICs): pharmacology and implication in pain","volume":"128","author":"Deval","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"26","key":"10.1016\/j.neuropharm.2024.110002_bib12","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110002_bib13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2021.03.025","article-title":"Decreasing trends in opioid prescribing on discharge to hospice care","volume":"62","author":"Furuno","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.neuropharm.2024.110002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.forc.2021.100321","article-title":"Fast & fluorinated \u2013 development and validation of a rapid benchtop NMR approach and other routine screening methods for the detection and quantification of synthesized fluorofentanyl derivatives","volume":"23","author":"Gilbert","year":"2021","journal-title":"Forensic Chemistry"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110002_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-016-4492-6","article-title":"Self-administration and behavioral economics of second-generation synthetic cathinones in male rats","volume":"234","author":"Huskinson","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110002_bib16","article-title":"Agonist that activates the mu-opioid receptor in acidified microenvironments inhibits colitis pain without side effects","author":"Jimenez-Vargas","year":"2021","journal-title":"Gut"},{"issue":"6852","key":"10.1016\/j.neuropharm.2024.110002_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110002_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","article-title":"The United States opioid epidemic","volume":"43","author":"Lyden","year":"2019","journal-title":"Semin. Perinatol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110002_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110002_bib20","article-title":"Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus","volume":"82","author":"Martinov","year":"2013","journal-title":"JoVE"},{"issue":"18","key":"10.1016\/j.neuropharm.2024.110002_bib21","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1001\/jama.290.18.2470","article-title":"A capsule history of pain management","volume":"290","author":"Meldrum","year":"2003","journal-title":"JAMA"},{"issue":"5185","key":"10.1016\/j.neuropharm.2024.110002_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/bmj.1.5185.1521","article-title":"Biochemical mechanisms in inflammation","volume":"1","author":"Menkin","year":"1960","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110002_bib23","first-page":"57","article-title":"Practical applications of monitoring respiratory mechanics in newborn","volume":"51","author":"Migliori","year":"1999","journal-title":"Minerva Pediatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110002_bib24","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","article-title":"Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human","volume":"164","author":"Morgan","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110002_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1037\/a0013634","article-title":"The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse","volume":"16","author":"Passik","year":"2008","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"29","key":"10.1016\/j.neuropharm.2024.110002_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jxb\/10.2.290","article-title":"A flexible growth function for empirical use","volume":"10","author":"Richards","year":"1959","journal-title":"J. Exp. Bot."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110002_bib27","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1097\/j.pain.0000000000001328","article-title":"Analgesic effects of a novel pH-dependent mu-opioid receptor agonist in models of neuropathic and abdominal pain","volume":"159","author":"Rodriguez-Gaztelumendi","year":"2018","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110002_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/acsmedchemlett.9b00335","article-title":"Beta-fluorofentanyls are pH-sensitive mu opioid receptor agonists","volume":"10","author":"Rosas","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"6328","key":"10.1016\/j.neuropharm.2024.110002_bib29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib30","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1038\/s41598-018-27313-4","article-title":"Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist","volume":"8","author":"Spahn","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110002_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(94)90130-9","article-title":"Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain","volume":"58","author":"Sufka","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-27699-w","article-title":"Modelling altered signalling of G-protein coupled receptors in inflamed environment to advance drug design","volume":"13","author":"Thies","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110002_bib32","first-page":"S88","article-title":"Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice","volume":"30","author":"Thomsen","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110002_bib33","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00213-017-4652-3","article-title":"Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats","volume":"234","author":"Townsend","year":"2017","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110002_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1213\/ANE.0b013e3182918098","article-title":"Special article: evaluation of a novel noninvasive respiration monitor providing continuous measurement of minute ventilation in ambulatory subjects in a variety of clinical scenarios","volume":"117","author":"Voscopoulos","year":"2013","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110002_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00000542-200408000-00029","article-title":"Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain","volume":"101","author":"Woo","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110002_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2018.08.002","article-title":"The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats","volume":"192","author":"Zamarripa","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110002_bib37","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s00213-021-05965-x","article-title":"The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats","volume":"238","author":"Zamarripa","year":"2021","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:05:49Z","timestamp":1717567549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S0028390824001710"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pKa fluorinated fentanyl analogs, FF3 and NFEPP","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110002"}}